Teva (TEVA) Hits Multi-Year High as Q3 Strengthens FY25 Profitability Expectations [Yahoo! Finance]
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.tevapharm.com
Company Research
Source: Yahoo! Finance
Teva rallied to a new multi-year high on Wednesday after a stellar performance in the third quarter solidified expectations for a profitable full-year 2025. In intra-day trading, Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) jumped to $25 before trimming gains to finish the day just up by 20.23 percent at $24.60 apiece. This followed the company's net income of $460 million in the third quarter of the year, marking a 211 percent improvement from the $390 million net loss in the same period last year. Teva (TEVA) Hits All-Time High as Q3 Strengthens FY25 Profitability Expectations Revenues grew by 3.4 percent to $4.48 billion from $4.33 billion year-on-year, on the back of strong growth across its brands Austedo, Ajovy, and Uzedy, with sales jumping by 38 percent, 19 percent, and 24 percent, respectively. Despite the results, Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) reduced the upper range of its revenue growth outlook to $17 billion from $17.2 billion previously, w
Show less
Read more
Impact Snapshot
Event Time:
TEVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TEVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TEVA alerts
High impacting Teva Pharmaceutical Industries Limited American Depositary Shares news events
Weekly update
A roundup of the hottest topics
TEVA
News
- Teva Pharmaceutical Industries (NYSE:TEVA) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $35.00 price target on the stock.MarketBeat
- Why Teva Pharmaceutical Industries Ltd. (TEVA) is a Top Value Stock for the Long-Term [Yahoo! Finance]Yahoo! Finance
- Why Hall Of Famer Terrell Davis Is Talking About The ‘Other TD' [Forbes]Forbes
- With 72% ownership in Teva Pharmaceutical Industries Limited (NYSE:TEVA), institutional investors have a lot riding on the business [Yahoo! Finance]Yahoo! Finance
- Is Teva a Bargain After 27% Surge and Cost-Cutting Headlines? [Yahoo! Finance]Yahoo! Finance
TEVA
Earnings
- 11/5/25 - Beat
TEVA
Sec Filings
- 12/4/25 - Form 4
- 12/1/25 - Form 4
- 11/26/25 - Form 144
- TEVA's page on the SEC website